Skip to main content
Journal cover image

A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB

Publication ,  Conference
Affronti, ML; Woodring, S; Herndon, JE; McSherry, F; Peters, KB; Friedman, HS; Desjardins, A; Freeman, W; Cheshire, S; Cone, C; Kalinowski, KH ...
Published in: NEURO-ONCOLOGY
October 1, 2012

Duke Scholars

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2012

Volume

14

Start / End Page

156 / 156

Location

Washington, DC

Publisher

OXFORD UNIV PRESS INC

Conference Name

17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Affronti, M. L., Woodring, S., Herndon, J. E., McSherry, F., Peters, K. B., Friedman, H. S., … Vredenburgh, J. J. (2012). A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB. In NEURO-ONCOLOGY (Vol. 14, pp. 156–156). Washington, DC: OXFORD UNIV PRESS INC.
Affronti, Mary Lou, Sarah Woodring, James E. Herndon, Frances McSherry, Katherine B. Peters, Henry S. Friedman, Annick Desjardins, et al. “A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB.” In NEURO-ONCOLOGY, 14:156–156. OXFORD UNIV PRESS INC, 2012.
Affronti ML, Woodring S, Herndon JE, McSherry F, Peters KB, Friedman HS, et al. A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 156–156.
Affronti ML, Woodring S, Herndon JE, McSherry F, Peters KB, Friedman HS, Desjardins A, Freeman W, Cheshire S, Cone C, Kalinowski KH, Kim J-Y, Lay HH, Poillucci V, Southerland C, Tetterton J, Vredenburgh JJ. A PHASE II SINGLE-ARM TRIAL OF PALONOSETRON FOR THE PREVENTION OF ACUTE AND DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN MALIGNANT GLIOMA PATIENTS RECEIVING IRINOTECAN IN COMBINATION WITH BEVACIZUMAB. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2012. p. 156–156.
Journal cover image

Published In

NEURO-ONCOLOGY

ISSN

1522-8517

Publication Date

October 1, 2012

Volume

14

Start / End Page

156 / 156

Location

Washington, DC

Publisher

OXFORD UNIV PRESS INC

Conference Name

17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences